Xarelto Safety Suits Sent To Louisiana By MDL Panel

Law360, New York (December 12, 2014, 8:02 PM EST) -- The U.S. Judicial Panel on Multidistrict Litigation decided Friday to consolidate in Louisiana federal court nearly two dozen suits against Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer Corp. over the blood thinner Xarelto, finding that the cases have enough common factual questions to warrant centralization.

The JPML disagreed with the defendants, who had argued that the cases posed too many unique issues such as medical history and drug dosage, finding that such types of differences apply to nearly all product liability cases and don't necessarily preclude centralization.

In this case, the plaintiffs had posed common factual issues, including whether...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Judge

Subscribers Only

Date Filed

October 9, 2014

Law Firms

Companies